Full Professor(heuristic)

Colorectal Cancer Treatments and Studies · Oncology

Compare more Oncology professors.

h-index106
i10-index532
Publications1,849
Citations57,614

Grants

1 total · 1 active

NIH #UM1CA186717

Phase 1 and 2 Molecular and Clinical Pharmacodynamic Trials ETCTN

Active
Amount
$1M–$2M
Period
2014-03-28 → 2027-02-28
PIs
4

Awarded at BECKMAN RESEARCH INSTITUTE/CITY OF HOPE

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

1 total · 1 active

NIH #UM1CA186717

Phase 1 and 2 Molecular and Clinical Pharmacodynamic Trials ETCTN

Active
Amount
$1M–$2M
Period
2014-03-28 → 2027-02-28
PIs
4

Awarded at BECKMAN RESEARCH INSTITUTE/CITY OF HOPE

Recent Public Signals

  1. New preprint: Activation of the endocytosis pathway stratifies subtypes and therapeutic sensitivity in colorectal cancer2026-07-05
  2. New paper: Abstract 2105: Transcriptomic insights into MAO B inhibition and bevacizumab synergy in colorectal cancer model. (Cancer Research)2026-04-03
  3. New NIH award: Phase 1 and 2 Molecular and Clinical Pharmacodynamic Trials ETCTN2014-03-28

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0003-2178-9568

Professor Insights

Career Trajectory